Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Revenue

Intellia Therapeutics had revenue of $15.05M in the quarter ending March 31, 2026, a decrease of -9.50%. This brings the company's revenue in the last twelve months to $66.09M, up 45.04% year-over-year. In the year 2025, Intellia Therapeutics had annual revenue of $67.67M with 16.92% growth.

• Revenue (ttm): $66.09M
• Revenue Growth: +45.04%
• P/S Ratio: 28.31
• Revenue / Employee: $175,310
• Employees: 377
• Market Cap: 1.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.67M	9.79M	16.92%
Dec 31, 2024	57.88M	21.60M	59.55%
Dec 31, 2023	36.28M	-15.85M	-30.40%
Dec 31, 2022	52.12M	19.07M	57.69%
Dec 31, 2021	33.05M	-24.94M	-43.01%
Dec 31, 2020	57.99M	14.89M	34.55%
Dec 31, 2019	43.10M	12.67M	41.63%
Dec 31, 2018	30.43M	4.32M	16.53%
Dec 31, 2017	26.12M	9.64M	58.49%
Dec 31, 2016	16.48M	10.44M	172.65%
Dec 31, 2015	6.04M	-	-

Data Source: Fiscal.ai Last updated: May 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error